GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (XSWX:ZBH) » Definitions » Valuation Rank

Zimmer Biomet Holdings (XSWX:ZBH) Valuation Rank


View and export this data going back to 2003. Start your Free Trial

What is Zimmer Biomet Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Zimmer Biomet Holdings Valuation Rank Related Terms

Thank you for viewing the detailed overview of Zimmer Biomet Holdings's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Zimmer Biomet Holdings (XSWX:ZBH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (XSWX:ZBH) » Definitions » Valuation Rank
Comparable Companies
ALGN STE BRKR SWAV PODD BIO PEN MASI GMED INSP TSE:5212 ABT SYK MDT BSX EW DXCM SZSE:300760 XAMS:PHIA XSWX:SOON
Traded in Other Exchanges
ZBH:USA ZIM:Germany ZBH:Austria
Address
345 East Main Street, Warsaw, IN, USA, 46580
Website
https://www.zimmerbiomet.com
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.